An aim of the study was to determine the protein expression of the FAS-related apoptosis signaling pathway (FADD-FAS Associating Protein with Death Domain, PRO-CASPASE-8 and CASPASE-8), which are responsible for signal transduction to trigger programmed cell death (apoptosis) in cancer and Prostatic Intraepitelial Neoplasia (PIN). 20 specimens from prostate cancer patients treated with radical prostatectomy were inwestigated. 8 cancers were diagnosed as G-2 and 12 as G-3. 14 samples were described as poorly differentiated, high Gleason score (> or = 7). Control group consisted of prostate specimens from autopsy of 3 young men. Specimens were fixed in 10% buffered formaldehyde and immersed in paraffin. Haematoxylin and eosin staining was done. Monoclonal antibodies to FADD & CASPASE-8 (Novocastra, UK) were used to immunohistochemical study, according to streptavidine-biotin method. Semiquantitive method described protein expression. Expression index (EI) was calculated as a percent of positive FADD or CASPASE-8 cells to total cells in the specimen. Statistical analysis was performed with the Student t-test (p < 0.05). Normal prostate tissue was negative in both, FADD and CASPASE-8 immunohistochemistry staining. PIN & prostate cancer lesions were found to strongly express of FADD & CASPASE-8 proteins. Expression of FADD in cancer lesions was 66,5+/-27,8% and 59,8+/-19,0% vs. 56,8114,8% HGPIN and LGPIN, respectively. Expression of CASPASE-8 in cancer lesions was 64,1 + 23,4% and 61,5+/-15,0% vs. 48,0+/-17,6% HGPIN and LGPIN, respectively. PIN & prostate cancer lesions are characterized by similar high expression of proteins responsible for signal transduction to induce apoptosis. The mediators of apoptotic signal can be very important in prostate cancer prophylaxis and management.
Download full-text PDF |
Source |
---|
Support Care Cancer
January 2025
Oral Diagnosis Department, Faculdade de Odontolodia de Piracicaba, Universidade de Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.
Purpose: Oral mucositis (OM) reflects a complex interplay of several risk factors. Machine learning (ML) is a promising frontier in science, capable of processing dense information. This study aims to assess the performance of ML in predicting OM risk in patients undergoing head and neck radiotherapy.
View Article and Find Full Text PDFChem Biodivers
January 2025
University of South China, Department of Gastroenterology, Chuanshan Road, Hengyang, CHINA.
The formation of gastric precancerous-lesions (GPLs) has been identified as a critical step in tumorigenesis, and patients with GPLs have an increased risk of gastric cancer. Magnolol is the primary biphenolic compound in Magnolia officinalis. It possesses various pharmacological properties, such as cardioprotective and neuroprotective properties, and inhibit tumor growth.
View Article and Find Full Text PDFBackground: Colorectal cancer (CRC) claims 900,000 lives per year. Colonoscopy offers reliable detection, but with low patient adherence rates. To significantly reduce CRC incidence and mortality, a more convenient screening measure for advanced precancerous lesions (APL) and CRC is urgently needed.
View Article and Find Full Text PDFRadiology
January 2025
From the Department of Radiology, Duke University Hospital, 2301 Erwin Rd, Box 3808, Durham, NC 27701 (B.W.T., K.R.K., B.C.A., S.P.T., D.E.K., B.H., M.R.B., D.M., E.S., E.A.); Department of Biostatistics and Bioinformatics (N.F., S.M., A.E.) and Department of Medical Physics (W.P.S., E.S., E.A.), Duke University, Durham, NC.
Background Detection of hepatic metastases at CT is a daily task in radiology departments that influences medical and surgical treatment strategies for oncology patients. Purpose To compare simulated photon-counting CT (PCCT) with energy-integrating detector (EID) CT for the detection of small liver lesions. Materials and Methods In this reader study (July to December 2023), a virtual imaging framework was used with 50 anthropomorphic phantoms and 183 generated liver lesions (one to six lesions per phantom, 0.
View Article and Find Full Text PDFRadiology
January 2025
From the Departments of Radiology and Population Health, New York University Langone Medical Center, New York, NY (S.K.K.); Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Wash (R.G.); Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY (N.M., C.H.); Herbert Irving Comprehensive Cancer Center, New York, NY (C.H., E.B.E.); and Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY (E.B.E.).
Multi-cancer early detection (MCED) tests are already being marketed as noninvasive, convenient opportunities to test for multiple cancer types with a single blood sample. The technology varies-involving detection of circulating tumor DNA, fragments of DNA, RNA, or proteins unique to each targeted cancer. The priorities and tradeoffs of reaching diagnostic resolution in the setting of possible false positives and negatives remain under active study.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!